A Phase 3 interventional study of Experimental Oral Nutritional Supplement in Pneumonia, sponsored by Abbott Nutrition. Terminated at 14 sites in 2 countries. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2013-02-15.
Sponsored by Abbott Nutrition · Phase 3, Interventional, and Treatment
Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 17 is below the median of 106 across 1,247 interventional studies indexed under Pneumonia.
Browse Pneumonia studies →Abbott Nutrition is the lead sponsor of 153 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Experimental ONS orally Two 8 fl oz servings/day
Other: Experimental Oral Nutritional Supplement
Experimental ONS orally Two 8 fl oz servings/day
Leg Lean Mass
Time frame: baseline to day 30
Body Weight
Time frame: baseline to day 30
Body Mass Index
Time frame: baseline to day 30
Activities of daily living
Time frame: baseline to day 30
This study is terminated, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abbott Nutrition